• Latest Posts
More News! 2 Feb 2017

Galapagos kicks off a Phase IIa trial for Cystic Fibrosis

Galapagos gets another Milestone Payment from Gilead

One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

Galapagos Hangs On: Filgotinib enters Phase III for Rheumatoid Arthritis

Which European Biotechs made it to the Billion-Euro Club in 2016?


Galapagos and AbbVie expand their Cystic Fibrosis collaboration

Two of the Biggest European Biotechs launch Antibody Program together

Why is J&J getting rid of Galapagos’ shares, when Everyone else is Buying?

Groningen’s MedTech Hub for Neurosurgery is Actually a Biotech Hotspot

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal